Steve Blank wrote an excellent 3 part blog series last week. We covered Part 1 which described the challenges Life Science companies face in...

The US giant has been given a virtual outsourcing platform for Pfizer scientists called the MXIS (Market Exchange for Innovative Services) via...

In a recent case study by Scientist, Joe Payne told us of this rule of thumb. “If you need the compound in 3 hours, make it in house; 3 days...

Interesting news for those thinking about personalized medicine and drug development: children born to mothers after bariatric gastrointestinal...

Life science companies are known to be one of the most expensive and difficult to start up. We look for an answer as to why in an excellent article...

This month Drug Discovery News published Dr. Kevin Lustig’s editorial discussing how outsourcing is a viable strategy for advancing oncology...

In spite of advances in biology and medicine, cancer remains a major unmet clinical need. In the pharmaceutical and biotechnology worlds, cancer...

Scientist, which has created an Amazon-like service for buying research services, has landed drug giant Pfizer ($PFE) as a new customer. Pfizer has...

As you know, we founded Scientist based on our belief that we must tap into the enormous amount of latent scientific talent all around us in order...

CIO recently held the CIO100 Symposium and Awards Ceremony, where they honor innovative and successful IT leaders in a range of industries. We are...